Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-11-21
2011-10-11
Desai, Anand (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S300000
Reexamination Certificate
active
08034774
ABSTRACT:
Peptide compounds and methods for upregulating expression of a gene encoding an antioxidative enzyme, such as superoxide dismutase or catalase, to counteract harmful oxidative effects of reactive oxygen species and other free radicals are described. The peptide compounds may be used to treat or prevent diseases and conditions characterized by undesirable elevation of reactive oxygen species and other free radicals, to upregulate AP-1 gene expression, and to treat pain. The peptide compounds may be used as components of pharmaceuticals and dietary supplements.
REFERENCES:
patent: 3953418 (1976-04-01), Yanaihara et al.
patent: 4277464 (1981-07-01), Reusiner et al.
patent: 4297344 (1981-10-01), Schwinn et al.
patent: 4783441 (1988-11-01), Thurow
patent: 4812557 (1989-03-01), Yasushi et al.
patent: 5096885 (1992-03-01), Pearlman et al.
patent: 5098893 (1992-03-01), Franks et al.
patent: 5112870 (1992-05-01), Mao et al.
patent: 5242901 (1993-09-01), Speyer et al.
patent: 5455029 (1995-10-01), Hartman et al.
patent: 5538878 (1996-07-01), Thomas et al.
patent: 5540933 (1996-07-01), Ruoslahti et al.
patent: 5545719 (1996-08-01), Shashoua
patent: 5559095 (1996-09-01), Miljanich et al.
patent: 5766857 (1998-06-01), Ruoslahti et al.
patent: 5804427 (1998-09-01), Davis et al.
patent: 5962634 (1999-10-01), Jameson et al.
patent: 5972985 (1999-10-01), Thomas et al.
patent: 5981478 (1999-11-01), Ruoslahti et al.
patent: 6174862 (2001-01-01), Brenneman
patent: 6225444 (2001-05-01), Shashoua
patent: 6242577 (2001-06-01), Ruoslahti et al.
patent: 6469049 (2002-10-01), Meyerhoff et al.
patent: 6613887 (2003-09-01), Ogi et al.
patent: 6627601 (2003-09-01), Shashoua
patent: 6645501 (2003-11-01), Dowdy
patent: 6890896 (2005-05-01), Shashoua
patent: 7524819 (2009-04-01), Shashoua
patent: 2001/0034035 (2001-10-01), Shashoua
patent: 2005/0090446 (2005-04-01), Shashoua
patent: 2006/0019901 (2006-01-01), Shashoua
patent: 0 488 979 (1991-10-01), None
patent: 0 497 341 (1992-05-01), None
patent: 0 567 886 (1993-11-01), None
patent: 2099067 (1997-12-01), None
patent: WO 92/20362 (1992-11-01), None
patent: WO 96/01643 (1996-01-01), None
patent: WO 96/12505 (1996-05-01), None
patent: WO 97/06815 (1997-02-01), None
patent: WO 99/26620 (1999-06-01), None
patent: WO 99/40112 (1999-08-01), None
patent: WO 99/46823 (1999-09-01), None
patent: WO 01/36454 (2001-05-01), None
patent: WO 01/79272 (2001-10-01), None
patent: WO 02/27016 (2002-04-01), None
patent: WO 03/066814 (2002-08-01), None
patent: WO 02/092781 (2002-11-01), None
patent: WO 02/096360 (2002-12-01), None
patent: WO 03/022226 (2003-03-01), None
patent: WO 2006/101909 (2006-09-01), None
patent: WO 2006/101910 (2006-09-01), None
Adams et al., Activation of a rel-A/CEBP-beta-related transcription factor heteromer by PGG-glucan in a murine monocytic cell line. J Cell Biochem. Mar. 2000;77(2):221-33.
Adams et al., Cloning and sequencing the genes encoding goldfish and carp ependymin. Gene. Apr. 20, 1994;141(2):237-41.
Adams et al., Genes encoding giant danio and golden shiner ependymin. Neurochem Res. Mar. 1996;21(3):377-84.
Adams et al., PGG-Glucan activates NF-kappaB-like and NF-IL-6-like transcription factor complexes in a murine monocytic cell line. J Leukoc Biol. Dec. 1997;62(6):865-73.
Adang et al., The glutathione-binding site in glutathione S-transferases. Investigation of the cysteinyl, glycyl and gamma-glutamyl domains. Biochem J. Jul. 1, 1990;269(1):47-54.
Altschul et al., Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. Sep. 1, 1997;25(17):3389-402. Review.
Angel et al., Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell. Jun. 19, 1987;49(6):729-39.
Bederson et al., Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. Nov.-Dec. 1986;17(6):1304-8.
Beyer et al., Assaying for superoxide dismutase activity: some large consequences of minor changes in conditions. Anal Biochem. Mar. 1987;161(2):559-66.
Bodansky and Bodansky, The Practice of Peptide Synthesis. New York: Springer Verlag, 1984.
Brenneman et al., Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides. J Pharmacol Exp Ther. May 1998;285(2):619-27.
Büllesbach et al., Naturally occurring porcine relaxins and large-scale preparation of the B29 hormone. Biochemistry. Dec. 17, 1985;24(26):7717-22.
Carpenter et al., Rational design of stable lyophilized protein formulations: some practical advice. Pharm Res. Aug. 1997;14(8):969-75. Review.
Ceballos-Picot et al., [Transgenic mice overexpressing copper-zinc superoxide dismutase: a model for the study of radical mechanisms and aging] C R Seances Soc Biol Fil. 1993;187(3):308-23. Review. French.
Chan et al., Neuroprotective role of CuZn-superoxide dismutase in ischemic brain damage. Adv Neurol. 1996;71:271-280.
Cornell-Bell et al., Ca2+ waves in astrocytes. Cell Calcium. Feb.-Mar. 1991;12(2-3):185-204.
Cornell-Bell et al., Glutamate induces calcium waves in cultured astrocytes: long-range glial signaling. Science. Jan. 26, 1990;247(4941):470-3.
Del Arco et al., JNK (c-Jun NH2-terminal kinase) is a target for antioxidants in T lymphocytes. J Biol Chem. Oct. 18, 1996;271(42):26335-40.
Diguiseppi et al., The toxicology of molecular oxygen. Crit Rev Toxicol. 1984;12(4):315-42. Review.
Erdincler et al., Lipid peroxidation and antioxidant status in experimental animals: effects of aging and hypercholesterolemic diet. Clin Chim Acta. Sep. 8, 1997;265(1):77-84.
Fischer et al., Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis. Mol Pharmacol. Nov. 1991;40(5):846-53.
Fridovich et al., Superoxide dismutases. Adv Enzymol Relat Areas Mol Biol. 1974;41(0):35-97. Review.
Gentry et al., Nerve growth factor activation of nuclear factor kappaB through its p75 receptor is an anti-apoptic signal in RN22 schwannoma cells. J Biol Chem. Mar. 17, 2000;275(11):7558-65.
Gregorio-King et al., MERP1: a mammalian ependymin-related protein gene differentially expressed in hematopoietic cells. Gene. Mar. 20, 2002;286(2):249-57.
Halliwell, B. and Gutteridge, J.M.C., eds. Free Radicals in Biology and Medicine. Oxford: Clarendon Press, 1989.
Hanks et al., Relation of oxygen and temperature in the preservation of tissues by refrigeration. Proc Soc Exp Biol Med. Jun. 1949;71(2):196-200.
Horvitz et al., The genetics of programmed cell death in the nematode Caenorhabditis elegans. Cold Spring Harb Symp Quant Biol. 1994;59:377-85. Review.
Hsu et al., Expression of immediate early gene and growth factor mRNAs in a focal cerebral ischemia model in the rat. Stroke. Dec. 1993;24(12 Suppl):178-81.
Huang et al., [Leukogenic effect and antioxygen radicals function of fufang wuzi yanzong pills] Zhongguo Zhong Yao Za Zhi. Jul. 1991;16(7):414-6, 447. Chinese.
Jornot et al., Hyperoxia, unlike phorbol ester, induces glutathione peroxidase through a protein kinase C-independent mechanism. Biochem J. Aug. 15, 1997;326 ( Pt 1):117-23.
Kaiser et al., Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal Biochem. Apr. 1970;34(2):595-8.
Lehninger A.L. Biochemistry. Second edition. New York: Worth Publishers, Inc. 1975; 72.
Leker et al., NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death. Stroke. Apr. 2002;33(4):1085-92.
Li et al., [Effects of wuzi yanzong pills on lipid in rats with alcohol-induced liver injury] Zhongguo Zhong Yao Za Zhi. May 1994;19(5):300-2, inside backcover.
Li et al., Delayed triphenyltetrazolium chloride staining remains useful for evaluating cerebral infarct volume in a rat stroke model. J Cereb Blood Flow Metab. Oct. 1997;17(10):1132-5.
Longa et al., Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. Jan. 1989;20(1):84-91.
Longo et al., Synthetic NGF peptide derivatives prevent neuronal death via a p75 receptor-dependent mechanism. J Neurosci Res. Apr. 1,
Desai Anand
Ischemix, Inc.
Wolf Greenfield & Sacks P.C.
LandOfFree
Compositions and methods for counteracting effects of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for counteracting effects of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for counteracting effects of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4274427